FDA Law Blog

DECEMBER 4, 2023

The government asserted additional allegations that are outside our scope. 12, 2012). “[W]hen the circumstances surrounding the presentation of a prescription would give rise to suspicion in a ‘reasonable professional,’ there is a duty to question the prescription.” Zarzamora Press Release. Consent Agreement and Final Judgment 2-3.

Treatment Plan 139

Treatment Plan ER Government Patient-Centered 139

FDA Law Blog

JANUARY 15, 2024

Koblitz — You know a court decision is going to be worth reading when the judges compare FDA’s regulatory governance of flavored e-cigarettes to a Shakespearean gaslighting. Let’s just say, the smackdown—er, decision—eviscerates FDA’s approach to regulating flavored e-cigarettes. By David B. Clissold & Sara W.

Manufacturing 115

Manufacturing IT Provider ER 115

GeriPal

MARCH 6, 2025

He was a person with schizophrenia, he was a person who used drugs and he presented in pain crisis to our shelter. You know, we found that 64% of the people we cared for never went to the hospital or ER. So, you know, I just wanted to present a couple options and give you a sense of, you know, the background for both.

Healthcare 100

Healthcare IT Community Illness 100

GeriPal

SEPTEMBER 5, 2024

So elderly people who aspirated, got pneumonia, had an mi, didn’t get hauled off to the emergency room on an ambulance crew so they could die in the ER. And he had a deadly fear of being institutionalized, based on his previous present experience. The intention was to place it in the beds in nursing homes. His hands were gone.

Patients 98

Patients IT Patient-Centered Hospital 98